WebMD: Aqvesme: FDA Approves First Pill for Treating Anemia in Adults With Alpha- or Beta- Thalassemia What Is Aqvesme, and Why Does It Matter? Aqvesme (mitapivat) is a new oral medicine approved by the FDA for treating anemia in adults with alpha- or beta-thalassemia, including those who need and ... Aqvesme: FDA Approves First Pill for Treating Anemia in Adults With Alpha- or Beta- Thalassemia Nasdaq: FDA Approves Agios' AQVESME For Treatment Of Anemia In Alpha- And Beta-Thalassemia FDA Approves Agios' AQVESME For Treatment Of Anemia In Alpha- And Beta-Thalassemia People with thalassemia trait usually don’t have any symptoms.
In certain cases, like during pregnancy, thalassemia carriers may have symptoms of mild anemia, such as fatigue or headaches. Thalassemia ... Whether you inherit alpha- or beta-thalassemia depends on which genes are affected. The number of affected genes can determine the subtype of alpha- or beta-thalassemia and the severity of your ...
alpha thalassemia symptoms, People with the thalassemia trait, or thalassemia carriers, may not experience any symptoms. However, some thalassemia carriers can experience anemia symptoms, such as paleness and fatigue. In people ...
